2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Biophotonics and Laser Technologies
Biophotonics and laser technologies are playing an increasingly vital role in cancer research, offering novel ways to detect and treat tumors with high precision. Biophotonics involves the use of light and laser-based tools to study biological materials and tissues, enabling researchers to visualize cancer cells at a molecular level. Techniques like fluorescence imaging and optical coherence tomography provide detailed images of tumors, aiding in early detection and monitoring of cancer progression. Laser therapy, on the other hand, uses focused light to target and destroy cancer cells with minimal damage to surrounding tissues. These technologies are particularly useful for treating tumors in delicate areas, such as the brain or eye, and are being explored for use in combination with other treatment modalities to improve overall cancer care.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China